Synthesis of 5-alkynylated d4T analogues as potential HIV-1 reverse transcriptase inhibitors. 2004

A Ciurea, and C Fossey, and D Gavriliu, and Z Delbederi, and E Sugeac, and D Laduree, and S Schmidt, and G Laumond, and A M Aubertin
Centre d'Etudes et de Recherche sur le Médicament de Normandie, UFR des Sciences Pharmaceutiques, F-14032 Caen Cedex, France.

A series of 2',3'-didehydro-2',3'-dideoxynucleosides substituted with an alkynylhydroxy- (6, 7, 12 and 13) and alkynylamino- (20) groups at the C-5 position were synthesized. All these five target modified nucleosides were tested for anti-human immunodeficiency virus type 1 activity in CEM-SS and MT-4 cells and unfortunately displayed no improvement in antiviral activity.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000480 Alkynes Hydrocarbons with at least one triple bond in the linear portion, of the general formula Cn-H2n-2. Acetylenic Compounds,Alkyne,Acetylenes
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines

Related Publications

A Ciurea, and C Fossey, and D Gavriliu, and Z Delbederi, and E Sugeac, and D Laduree, and S Schmidt, and G Laumond, and A M Aubertin
March 2021, ChemMedChem,
A Ciurea, and C Fossey, and D Gavriliu, and Z Delbederi, and E Sugeac, and D Laduree, and S Schmidt, and G Laumond, and A M Aubertin
February 2014, Antiviral research,
A Ciurea, and C Fossey, and D Gavriliu, and Z Delbederi, and E Sugeac, and D Laduree, and S Schmidt, and G Laumond, and A M Aubertin
June 2001, Bioorganic & medicinal chemistry letters,
A Ciurea, and C Fossey, and D Gavriliu, and Z Delbederi, and E Sugeac, and D Laduree, and S Schmidt, and G Laumond, and A M Aubertin
August 2005, Chemical & pharmaceutical bulletin,
A Ciurea, and C Fossey, and D Gavriliu, and Z Delbederi, and E Sugeac, and D Laduree, and S Schmidt, and G Laumond, and A M Aubertin
January 2003, Nucleosides, nucleotides & nucleic acids,
A Ciurea, and C Fossey, and D Gavriliu, and Z Delbederi, and E Sugeac, and D Laduree, and S Schmidt, and G Laumond, and A M Aubertin
August 2000, Bioorganic & medicinal chemistry letters,
A Ciurea, and C Fossey, and D Gavriliu, and Z Delbederi, and E Sugeac, and D Laduree, and S Schmidt, and G Laumond, and A M Aubertin
November 2009, Archiv der Pharmazie,
A Ciurea, and C Fossey, and D Gavriliu, and Z Delbederi, and E Sugeac, and D Laduree, and S Schmidt, and G Laumond, and A M Aubertin
October 2018, European journal of medicinal chemistry,
A Ciurea, and C Fossey, and D Gavriliu, and Z Delbederi, and E Sugeac, and D Laduree, and S Schmidt, and G Laumond, and A M Aubertin
June 2007, Applied microbiology and biotechnology,
A Ciurea, and C Fossey, and D Gavriliu, and Z Delbederi, and E Sugeac, and D Laduree, and S Schmidt, and G Laumond, and A M Aubertin
October 1992, Journal of medicinal chemistry,
Copied contents to your clipboard!